MELISSA SHREWSBURY: Open Payments
NPI 1124302260 · PRINCETON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 17 payments from 6 companies in 2025. Trend: 2023 $141 · 2024 $238 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $118 |
| Optinose US, Inc. | 3 | $72 |
| Organogenesis Inc. | 3 | $70 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $34 |
| Amgen Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: NUCALA, Xhance, TEZSPIRE, NEFFY, CYGNUS DUAL, SIMPLIMAX, PURAPLY WOUND MATRIX.
Industry payments across WV — which companies pay providers there.
